LMC Clinical Research Inc. (Brampton)
Brampton, Ontario, Canada
Diabetes center in Brampton, Ontario
2979 Bovaird Dr E, Brampton, ON L6S 0C6
About LMC Clinical Research Inc. (Brampton)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
LMC Diabetes & Endocrinology Ltd.
5
Boehringer Ingelheim
3
Eli Lilly and Company
3
Pfizer
3
Kowa Research Institute, Inc.
1
Clinical Trials at LMC Clinical Research Inc. (Brampton)
During the past decade, LMC Clinical Research Inc. (Brampton) conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
2017-01-01
2017-06-01
Completed
4,000
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
2019-01-31
2025-01-31
Active, not recruiting
6,609
The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
2018-10-02
2019-11-19
Completed
119
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "LMC Clinical Research Inc. (Brampton)" #1 sponsor was "LMC Diabetes & Endocrinology Ltd." with 5 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Kowa Research Institute, Inc."
with 3 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LMC Clinical Research Inc. (Brampton)"
#1 collaborator was "Abbott Diabetes Care" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at LMC Clinical Research Inc. (Brampton)
According to Clinical.Site data, the most researched conditions in "LMC Clinical Research Inc. (Brampton)" are
"Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Chronic Kidney Disease" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "LMC Clinical Research Inc. (Brampton)" in a lesser frequency.
Clinical Trials Intervention Types at LMC Clinical Research Inc. (Brampton)
Most popular intervention types in "LMC Clinical Research Inc. (Brampton)" are "Drug" (12 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "BI 456906" (1 trials). Other intervention names were less common.
Clinical Trials Genders at LMC Clinical Research Inc. (Brampton)
The vast majority of trials in "LMC Clinical Research Inc. (Brampton)" are
15 trials for "All" genders.
Clinical Trials Status at LMC Clinical Research Inc. (Brampton)
Currently, there are NaN active trials in "LMC Clinical Research Inc. (Brampton)".
undefined are not yet recruiting,
1 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in LMC Clinical Research Inc. (Brampton),
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in LMC Clinical Research Inc. (Brampton), 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".